Menu
GWAS Study

An enhancer variant at 16q22.1 predisposes to hepatocellular carcinoma via regulating PRMT7 expression.

Shen T, Ni T, Chen J et al.

35264579 PubMed ID
GWAS Study Type
11958 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

ST
Shen T
NT
Ni T
CJ
Chen J
CH
Chen H
MX
Ma X
CG
Cao G
WT
Wu T
XH
Xie H
ZB
Zhou B
WG
Wei G
SH
Saiyin H
SS
Shen S
YP
Yu P
XQ
Xiao Q
LH
Liu H
GY
Gao Y
LX
Long X
YJ
Yin J
GY
Guo Y
WJ
Wu J
WG
Wei GH
HJ
Hou J
JD
Jiang DK
Chapter II

Abstract

Summary of the research findings

Most cancer causal variants are found in gene regulatory elements, e.g., enhancers. However, enhancer variants predisposing to hepatocellular carcinoma (HCC) remain unreported. Here we conduct a genome-wide survey of HCC-susceptible enhancer variants through a three-stage association study in 11,958 individuals and identify rs73613962 (T > G) within the intronic region of PRMT7 at 16q22.1 as a susceptibility locus of HCC (OR = 1.41, P = 6.02 × 10-10). An enhancer dual-luciferase assay indicates that the rs73613962-harboring region has allele-specific enhancer activity. CRISPR-Cas9/dCas9 experiments further support the enhancer activity of this region to regulate PRMT7 expression. Mechanistically, transcription factor HNF4A binds to this enhancer region, with preference to the risk allele G, to promote PRMT7 expression. PRMT7 upregulation contributes to in vitro, in vivo, and clinical HCC-associated phenotypes, possibly by affecting the p53 signaling pathway. This concept of HCC pathogenesis may open a promising window for HCC prevention/treatment.

1,161 Chinese ancestry cases, 1,353 Chinese ancestry controls

Chapter III

Study Statistics

Key metrics and study information

11958
Total Participants
GWAS
Study Type
Yes
Replicated
3,737 Chinese ancestry cases, 5,707 Chinese ancestry controls
Replication Participants
East Asian
Ancestry
China
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.